Motco Has $275,000 Stake in The Clorox Company $CLX

Motco decreased its position in The Clorox Company (NYSE:CLX) by 4.9% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,190 shares of the company’s stock after selling 114 shares during the quarter. Motco’s holdings in Clorox were worth $275,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. American National Bank & Trust grew its position in shares of Clorox by 69.5% in the second quarter. American National Bank & Trust now owns 217 shares of the company’s stock valued at $26,000 after purchasing an additional 89 shares during the last quarter. Ransom Advisory Ltd acquired a new position in shares of Clorox in the first quarter valued at approximately $35,000. GW&K Investment Management LLC grew its position in shares of Clorox by 239.1% in the first quarter. GW&K Investment Management LLC now owns 295 shares of the company’s stock valued at $43,000 after purchasing an additional 208 shares during the last quarter. Roble Belko & Company Inc grew its position in shares of Clorox by 140.7% in the first quarter. Roble Belko & Company Inc now owns 361 shares of the company’s stock valued at $53,000 after purchasing an additional 211 shares during the last quarter. Finally, Bogart Wealth LLC grew its position in shares of Clorox by 289.5% in the second quarter. Bogart Wealth LLC now owns 370 shares of the company’s stock valued at $44,000 after purchasing an additional 275 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Insiders Place Their Bets

In other news, COO Eric H. Reynolds sold 15,041 shares of the stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the transaction, the chief operating officer directly owned 54,221 shares in the company, valued at approximately $6,711,475.38. This represents a 21.72% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.63% of the stock is owned by insiders.

Analyst Ratings Changes

CLX has been the subject of several recent research reports. BNP Paribas Exane cut their price target on Clorox from $118.00 to $110.00 and set an “underperform” rating for the company in a research note on Friday, October 17th. Deutsche Bank Aktiengesellschaft cut their price target on Clorox from $135.00 to $128.00 and set a “hold” rating for the company in a research note on Monday, October 13th. TD Cowen cut their price target on Clorox from $120.00 to $117.00 and set a “hold” rating for the company in a research note on Wednesday, October 1st. Citigroup cut their price target on Clorox from $135.00 to $130.00 and set a “neutral” rating for the company in a research note on Wednesday, October 8th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Clorox in a research note on Tuesday, October 14th. One equities research analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and four have given a Sell rating to the company’s stock. According to data from MarketBeat.com, Clorox has a consensus rating of “Reduce” and an average price target of $130.20.

Clorox Stock Down 3.9%

NYSE CLX opened at $110.73 on Thursday. The business has a fifty day moving average price of $120.78 and a two-hundred day moving average price of $126.29. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57. The Clorox Company has a fifty-two week low of $110.61 and a fifty-two week high of $171.37. The stock has a market capitalization of $13.48 billion, a PE ratio of 16.98, a PEG ratio of 0.96 and a beta of 0.52.

Clorox (NYSE:CLX) last released its earnings results on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, topping the consensus estimate of $2.24 by $0.63. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The firm had revenue of $1.99 billion during the quarter, compared to analysts’ expectations of $1.94 billion. During the same period in the prior year, the company earned $1.82 earnings per share. The company’s quarterly revenue was up 4.5% on a year-over-year basis. Equities analysts expect that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd will be paid a dividend of $1.24 per share. The ex-dividend date is Wednesday, October 22nd. This represents a $4.96 annualized dividend and a yield of 4.5%. Clorox’s dividend payout ratio is presently 76.07%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.